Eterna Therapeutics Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eterna Therapeutics Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Eterna Therapeutics Inc. Current Ratio for the quarter ending June 30, 2024 was 78.6 %, a 45.5% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 78.6 -65.7 -45.5% Jun 30, 2024
Q1 2024 85.7 -124 -59.1% Mar 31, 2024
Q4 2023 94 -201 -68.2% Dec 31, 2023
Q3 2023 104 -268 -72% Sep 30, 2023
Q2 2023 144 -337 -70% Jun 30, 2023
Q1 2023 210 -411 -66.2% Mar 31, 2023
Q4 2022 295 -235 -44.3% Dec 31, 2022
Q3 2022 372 -85.2 -18.6% Sep 30, 2022
Q2 2022 481 +112 +30.2% Jun 30, 2022
Q1 2022 620 +488 +371% Mar 31, 2022
Q4 2021 531 +436 +460% Dec 31, 2021
Q3 2021 457 +353 +340% Sep 30, 2021
Q2 2021 369 +253 +218% Jun 30, 2021
Q1 2021 132 +8.72 +7.09% Mar 31, 2021
Q4 2020 94.7 -41.7 -30.6% Dec 31, 2020
Q3 2020 104 -55.8 -34.9% Sep 30, 2020
Q2 2020 116 -42.1 -26.6% Jun 30, 2020
Q1 2020 123 -25 -16.9% Mar 31, 2020
Q4 2019 136 -1.93 -1.4% Dec 31, 2019
Q3 2019 160 +42.3 +36.1% Sep 30, 2019
Q2 2019 158 +52.4 +49.4% Jun 30, 2019
Q1 2019 148 +46.4 +45.7% Mar 31, 2019
Q4 2018 138 +37.4 +37.1% Dec 31, 2018
Q3 2018 117 +3.49 +3.07% Sep 30, 2018
Q2 2018 106 -13.6 -11.3% Jun 30, 2018
Q1 2018 102 -24.7 -19.5% Mar 31, 2018
Q4 2017 101 -33.5 -24.9% Dec 31, 2017
Q3 2017 114 -22.5 -16.5% Sep 30, 2017
Q2 2017 120 -29.5 -19.8% Jun 30, 2017
Q1 2017 126 -40.9 -24.5% Mar 31, 2017
Q4 2016 134 -42 -23.8% Dec 31, 2016
Q3 2016 136 -49.1 -26.5% Sep 30, 2016
Q2 2016 149 -55.8 -27.2% Jun 30, 2016
Q1 2016 167 -55.2 -24.8% Mar 31, 2016
Q4 2015 176 -55 -23.8% Dec 31, 2015
Q3 2015 185 -51.7 -21.8% Sep 30, 2015
Q2 2015 205 -8.59 -4.03% Jun 30, 2015
Q1 2015 222 +53.1 +31.4% Mar 31, 2015
Q4 2014 231 +73.4 +46.5% Dec 31, 2014
Q3 2014 237 +107 +82.4% Sep 30, 2014
Q2 2014 213 +89.7 +72.6% Jun 30, 2014
Q1 2014 169 +53.5 +46.1% Mar 31, 2014
Q4 2013 158 +45.2 +40.1% Dec 31, 2013
Q3 2013 130 +30.1 +30.1% Sep 30, 2013
Q2 2013 124 +29 +30.7% Jun 30, 2013
Q1 2013 116 +20.4 +21.3% Mar 31, 2013
Q4 2012 113 Dec 31, 2012
Q3 2012 99.9 Sep 30, 2012
Q2 2012 94.6 Jun 30, 2012
Q1 2012 95.5 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.